Is Co-Dergocrine Mesilate compatible with breastfeeding? Do we have alternatives for Co-Dergocrine Mesilate?

Co-Dergocrine Mesilate

October 16, 2006 (Very High Risk)

Ergot-derivative alkaloid with an inhibiting effect on prolactin and dopamine release, used for treatment of brain vascular insufficiency and senile dementia. It may suppress lactation by inhibiting prolactin release.

Nonessential drug.

Alternatives

We do not have alternatives for Co-Dergocrine Mesilate.

Very Low Risk

Compatible. Not risky for breastfeeding or infant.

Low Risk

Moderately safe. Mild risk possible. Follow up recommended. Read the Comment.

High Risk

Poorly safe. Evaluate carefully. Use a safer alternative. Read the Comment.

Very High Risk

Not recommended. Cessation of breastfeeding or alternative.

Drug trade names

References

  1. [No authors listed] Do not use drugs to prevent onset of lactation. Relieve the discomfort and wait. Prescrire Int. 2013Abstract